Sativex ® in the treatment of bladder dysfunction in MS
Posted: Wed Sep 22, 2010 12:44 am
GW Pharmaceuticals plc announced that results of a Phase II clinical study of Sativex® (delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)) in the treatment of bladder dysfunction in people with Multiple Sclerosis (MS) have been published in the peer-reviewed Journal, Multiple Sclerosis.
The authors of the paper state that “this study does provide clinical evidence across a range of bladder-related endpoints that Sativex® has some beneficial effect when used for treatment of the bladder symptoms in patients with MS”. ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814